靶点针对疾病信息18(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Dopamine transporter (DAT)
INDICATI
Approved Attention deficit hyperactivity disorder [ICD-11: 6A05]
INDICATI
Approved Binge eating disorder [ICD-11: 6B82]
INDICATI
Approved Bipolar disorder [ICD-11: 6A60]
INDICATI
Approved Corneal disease [ICD-11: 9A76-9A78]
INDICATI
Approved Intracranial injury [ICD-11: NA07]
INDICATI
Approved Mood disorder [ICD-11: 6A60-6E23]
INDICATI
Approved Narcolepsy [ICD-11: 7A20]
INDICATI
Approved Obesity [ICD-11: 5B80-5B81]
INDICATI
Approved Parkinsonism [ICD-11: 8A00]
INDICATI
Phase 3 Dementia [ICD-11: 6D80-6D8Z]
INDICATI
Phase 3 Substance abuse [ICD-11: 6C40]
INDICATI
Phase 2 Cocaine use disorder [ICD-11: 6C45]
INDICATI
Phase 2 Depression [ICD-11: 6A70-6A7Z]
INDICATI
Phase 2 General pain disorder [ICD-11: 8E43]
INDICATI
Phase 2 Stomach disease [ICD-11: DA43-DA4Y]
INDICATI
Discontinued in Phase 1 Dissociative neurological symptom disorder [ICD-11: 6B60]